$2.07
0.115.61%
Last update: Nov 9, 4:23 PM
Genelux Corp
GNLXNASDAQ
Genelux fell 64.9% from $5.89 to $2.07, behind the S&P 500's +10.5%. Its worst day was Jan 5 (−23.5%), and its low came Nov 5 at $1.82.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Genelux closed at its highest level of the year, 1.5% above where the year started.
+1.5% · S&P 500 +0.2%
Genelux shares fell 16.4%, while the S&P 500 rose 0.1%.
−16.4% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
-- Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ongoing –-- In
−23.5%, the year's worst day · S&P 500 +0.7%
Genelux shares fell 11.6%, while the S&P 500 fell 0.9%.
−11.6% · S&P 500 −0.9%
EPS of $-0.24 missed the $-0.22 estimate on $0.00 revenue.
−5.5% · S&P 500 −1.4%
EPS of $-0.20 missed the $-0.19 estimate on $0.00 revenue.
+9.9%, the year's best day · S&P 500 +0.8%
Genelux shares fell 11.0%, while the S&P 500 fell 0.2%.
−11.0% · S&P 500 −0.2%
EPS of $-0.21 missed the $-0.20 estimate on $0.00 revenue.
−2.6% · S&P 500 +0.7%
Genelux shares fell 17.2%, while the S&P 500 rose 0.5%.
−17.2% · S&P 500 +0.5%
Where it ended: a close of $2.07 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.20).
Nothing in the past 12 months.
All GNLX dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GNLX and SPY from Benzinga historical bars. Not investment advice.
